Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin

Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin

Bibliographic Details
Main Authors: Kageaki Watanabe, MD, Rui Kitadai, MD, Shingo Kitagawa, MD, Takashi Toya, MD, Yukio Hosomi, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:JTO Clinical and Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320300515
Description
ISSN:2666-3643

Similar Items